The partnership illustrates industry investment in device education, while raising questions about independence, competency and regulatory scope.
What was announced?
Cytrellis Biosystems announced on 30 October 2026 that it will support an aesthetic medicine certificate programme developed by the Academy for Aesthetics and Anti-Aging Studies in academic partnership with the University of Miami School of Nursing and Health Studies. The company plans to bring its ellacor Micro-Coring device into hands-on workshops for participating nurse practitioners.
The first supported workshop was scheduled for 31 October at the university’s Coral Gables campus. This is an education and industry-partnership announcement, not the launch of a new device or a new FDA clearance.
What is micro-coring?
The ellacor platform mechanically removes very small columns of skin without using thermal energy. The method is distinct from conventional energy-based tightening procedures that deliver radiofrequency, ultrasound or laser energy. The company markets the system for treatment of selected wrinkles and laxity concerns, but precise FDA-cleared indications and patient selection should always be checked in the product’s official authorization documents.
Aesthetic device techniques require detailed anatomical knowledge, infection-control measures, appropriate training and careful management of complications. A new teaching partnership does not establish that the technique is appropriate for every skin type, anatomical site or provider.
How will the programme work?
According to Cytrellis, the certificate course runs for 12 weeks and includes 60 contact hours: 40 hours of on-campus classroom instruction and 20 hours of supervised clinical training. The company says it will provide a device, treatment tips, supplies and clinical educators for each of three annual cohorts.
The planned audience is qualified advanced practice registered nurses. Scope of practice differs by jurisdiction; a course certificate does not independently grant authorization to perform a procedure outside applicable licensing rules.
What are the broader implications?
As aesthetic medicine becomes increasingly technology-dependent, manufacturers are investing in training partnerships. Such programmes may improve familiarity with equipment and standardized workflows, but they also create potential conflicts of interest if educational material is presented without balanced discussion of alternatives and complications.
Independent assessment should ask whether training includes adverse-event recognition, contraindications, outcome documentation, device limitations and clear supervision. The company announcement does not provide data showing that the partnership improves patient outcomes. For the newsroom, this is a professional-education and device-industry story with important questions about transparency and competency.
A training partnership is not a clinical credential
Education in aesthetic medicine involves more than familiarity with a device interface. It includes assessment of indications and contraindications, consent, anatomy, sterile technique, emergency planning and referral pathways. Industry educators can contribute technical expertise, but programmes should disclose financial relationships and allow critical discussion of alternatives. The professional scope of a participant depends on applicable licensing rules and clinical supervision, not on completion of a manufacturer-supported workshop alone.
Original sources
Cytrellis company release, 30 October 2026: https://www.prnewswire.com/news-releases/cytrellis-named-strategic-industry-partner-of-aesthetic-medicine-certificate-program-at-university-of-miami-featuring-ellacor-micro-coring-technology-302924730.html
Source / evidence limitation: Company-issued partnership; independent confirmation of training outcomes and exact device labeling pending.
Medical disclaimer
This article is published by Aesthetics.news for general information and educational purposes only. It does not constitute medical advice, diagnosis or treatment, and should not replace a consultation with a qualified healthcare professional. Treatments and outcomes may vary from person to person. Readers should seek advice from an appropriately qualified professional before making decisions about their health or treatment. In a medical emergency, seek immediate medical assistance.
